Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

VYNE Therapeutics To Present Results Of Phase 1b Trial For VYN201 At 2024 Global Vitiligo Foundation Annual Scientific Symposium

Author: Benzinga Newsdesk | February 27, 2024 09:14am

Oral presentation on March 7, 2024 will review positive safety and efficacy data for novel BET inhibitor VYN201

Posted In: VYNE